AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
_6ff029a61766633234293.png?format=webp&width=1186&height=250)
Inspire Medical Systems CFO to Step Down, Initiates Search for New CFO
ByAinvest
Thursday, Aug 28, 2025 7:21 am ET1min read
Inspire Medical Systems' CFO, Richard J. Buchholz, will step down by December 31, 2025, to pursue other opportunities. He will remain in an advisory role until February 28, 2026. The company reaffirms its 2025 guidance of $900-910 million in revenue. Buchholz contributed to the company's growth from $4 million to over $800 million in 2024 and guided it through its IPO and COVID-19 pandemic challenges.
Inspire Medical Systems (NYSE: INSP), a medical technology company focused on innovative, minimally invasive solutions for patients with obstructive sleep apnea, has announced the departure of its Chief Financial Officer (CFO), Richard J. Buchholz. Buchholz will step down from his position effective December 31, 2025, to pursue other professional opportunities. He will continue to serve the company in an advisory role until February 28, 2026, to ensure a smooth transition [1].Buchholz has been with the company since 2014 and has played a pivotal role in its growth. Under his leadership, Inspire Medical Systems achieved significant milestones, including revenue growth from $4 million to over $800 million in 2024, successful completion of its initial public offering (IPO), and reaching profitability. The company has reaffirmed its 2025 financial guidance, projecting revenue of $900-910 million, a gross margin of 84-86%, and diluted earnings per share (EPS) of $0.40-$0.50 [1].
The departure of Buchholz comes amidst a positive financial outlook for the company. Inspire Medical Systems reported a notable revenue growth rate of 10.82% as of June 30, 2025, and achieved a high gross margin of 84.03%. However, the company's EPS was -0.12, indicating potential challenges in profitability [2].
The company is actively searching for a new CFO to lead the financial division. Investors are encouraged to monitor the search process and the company's ongoing financial performance. Inspire Medical Systems' stock has shown resilience, trading at $91.62 as of the latest update, despite Buchholz's stock option exercise valued at $722,202 [2].
References:
[1] https://www.stocktitan.net/news/INSP/inspire-medical-systems-inc-announces-departure-of-chief-financial-4d0tv9i76al8.html
[2] https://www.benzinga.com/insights/news/25/08/47284708/major-exercise-alert-richard-buchholz-exercises-options-worth-722k-at-inspire-medical-systems
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet